ATE417930T1 - Proteinkinase npk-110 - Google Patents

Proteinkinase npk-110

Info

Publication number
ATE417930T1
ATE417930T1 AT95937855T AT95937855T ATE417930T1 AT E417930 T1 ATE417930 T1 AT E417930T1 AT 95937855 T AT95937855 T AT 95937855T AT 95937855 T AT95937855 T AT 95937855T AT E417930 T1 ATE417930 T1 AT E417930T1
Authority
AT
Austria
Prior art keywords
protein kinase
npk
alzheimer
maps
cancer
Prior art date
Application number
AT95937855T
Other languages
English (en)
Inventor
Eckhard Mandelkow
Eva-Maria Mandelkow
Jacek Biernat
Gerard Drewes
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE417930T1 publication Critical patent/ATE417930T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT95937855T 1994-10-28 1995-10-30 Proteinkinase npk-110 ATE417930T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94117122 1994-10-28

Publications (1)

Publication Number Publication Date
ATE417930T1 true ATE417930T1 (de) 2009-01-15

Family

ID=8216419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937855T ATE417930T1 (de) 1994-10-28 1995-10-30 Proteinkinase npk-110

Country Status (12)

Country Link
US (2) US6579691B1 (de)
EP (1) EP0791067B1 (de)
JP (1) JPH10508199A (de)
KR (1) KR100275591B1 (de)
CN (1) CN1168699A (de)
AT (1) ATE417930T1 (de)
CA (1) CA2203910A1 (de)
DE (1) DE69535901D1 (de)
HU (1) HUT77081A (de)
NO (1) NO971966L (de)
NZ (1) NZ295371A (de)
WO (1) WO1996013592A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE398176T1 (de) * 1991-12-06 2008-07-15 Max Planck Gesellschaft Phosphorylierungsepitope aus dem tau-protein zur diagnose und behandlung der alzheimer-krankheit
WO1998049276A1 (en) * 1997-04-28 1998-11-05 Helix Research Institute Serine/threonine protein kinase
AU2001255763A1 (en) * 2000-04-25 2001-11-07 Millennium Pharmaceuticals, Inc. 13295 novel protein kinase molecules and uses therefor
EP1379628A2 (de) * 2000-12-06 2004-01-14 Incyte Genomics, Inc. Kinase und phosphatase sequenzen, und verwendung davon
US7119185B2 (en) * 2000-12-21 2006-10-10 Trustees Of The University Of Pennsylvania Hormonally up-regulated, neu-tumor-associated kinase
CN1549721B (zh) * 2001-02-27 2012-03-07 布朗歇特洛克菲勒神经科学研究所 基于促分裂原活化的蛋白激酶的磷酸化诊断阿尔茨海默氏病
WO2002099044A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. B3galts as modifiers of the p53 pathway and methods of use
US6492156B1 (en) * 2001-10-31 2002-12-10 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA2528043A1 (en) * 2003-06-19 2005-02-03 Exelixis, Inc. Marks as modifiers of the pten pathway and methods of use
US8273536B2 (en) 2003-06-19 2012-09-25 Exelixis, Inc. Marks as modifers of the PTEN pathway and methods of use
CN100424184C (zh) * 2005-12-09 2008-10-08 浙江大学 疱疹类病毒基因芯片及其应用
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
KR101294725B1 (ko) 2010-12-30 2013-08-08 연세대학교 산학협력단 인산화된 ｇｒａｓｐ를 포함하는 낭포성섬유증 치료용 약학 조성물
ES2656442T3 (es) * 2011-09-19 2018-02-27 Axon Neuroscience Se Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer
AU2018308088B2 (en) 2017-07-25 2025-05-29 Truebinding, Inc. Treating cancer by blocking the interaction of TIM-3 and its ligand
AU2020214796A1 (en) 2019-01-30 2021-07-29 Truebinding, Inc. Anti-Gal3 antibodies and uses thereof
WO2021242776A2 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3
CN117551674B (zh) * 2023-11-20 2024-10-18 内蒙古农业大学 沙葱萤叶甲微管亲和调节激酶GdMARK2基因的克隆及其功能

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544942A1 (de) * 1991-12-06 1993-06-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit

Also Published As

Publication number Publication date
US7485712B2 (en) 2009-02-03
NO971966D0 (no) 1997-04-28
CN1168699A (zh) 1997-12-24
NZ295371A (en) 1998-11-25
US20040038361A1 (en) 2004-02-26
WO1996013592A3 (en) 1996-08-01
MX9703101A (es) 1998-07-31
EP0791067A2 (de) 1997-08-27
AU714636B2 (en) 2000-01-06
EP0791067B1 (de) 2008-12-17
JPH10508199A (ja) 1998-08-18
US6579691B1 (en) 2003-06-17
US20030104516A1 (en) 2003-06-05
NO971966L (no) 1997-06-19
DE69535901D1 (de) 2009-01-29
KR100275591B1 (ko) 2001-02-01
WO1996013592A2 (en) 1996-05-09
CA2203910A1 (en) 1996-05-09
AU3870295A (en) 1996-05-23
HUT77081A (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
DE69535901D1 (de) Proteinkinase npk-110
EP0683234A4 (de) ANTIKÖRPER GEGEN -g(b)-AMYLOID ODER DERIVATE DAVON UND SEINE VERWENDUNG.
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
AR038568A1 (es) Anticuerpos anti-a beta y su uso
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
WO2002057259A3 (en) Pyrazole compounds useful as protein kinase inhibitors
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE212065T1 (de) Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung
WO2003028543A3 (en) Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
WO2003105773A3 (en) Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
DE69728897D1 (de) Saeugetierchemokine
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
EP0815240A4 (de) Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
WO2001064876A3 (en) Human schizophrenia gene
EP0780472A3 (de) Stress Proteine
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
WO2002072626A3 (de) Neue form des phgpx-proteins als diagnostischer marker bei männlicher infertilität
WO2001090156A3 (en) Card domain containing polypeptides, encoding nucleic acids, and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties